RGNX REGENXBIO Inc: Accounting Value per Share

Graphic logo of REGENXBIO Inc. (RGNX)

The market price action of REGENXBIO Inc. (RGNX) reflects the dynamics of a company minimizing capital expenditures by outsourcing production and testing to third-party contractors. The current metric stands at 1.33, while the business accumulates passive income from third-party drugs, although insurers will limit future pricing for its own products. The model relies on the ownership of exclusive gene delivery patents, which guarantees stable royalties from industry behemoths.

Regenxbio (RGNX) Equity per Share: for the period 07/04/2022 - 10/28/2026

regenxbio.com - analytical breakdowns and key metrics (RGNX)

- price and consensus price forecast:
Price Chart Regenxbio|RGNX - Broker Consensus Forecast
- market capitalization data:
Market Valuation REGENXBIO Inc.|RGNX - Business Value
- book capitalization data:
Book Value per Share REGENXBIO|RGNX - Accounting Capitalization|Market Value to Book Value Ratio regenxbio.com|RGNX - Total Business Assets
- debt and liquidity data:
Total Debt to Capital REGENXBIO Inc.|RGNX - Long-Term Debt to Capital|Short-Term Debt to Equity REGENXBIO|RGNX - Aggregate Debt Obligations|Debts to Book Capitalization REGENXBIO Inc.|RGNX - Long-Term Debt|Company Short-Term Debts REGENXBIO
Analysis of all company metrics:Regenxbio, RGNX
Manufactured products of REGENXBIO

Investors are assessing the resilience of REGENXBIO Inc. (RGNX) through the book value per share, calculated as the difference between total assets and liabilities divided by the number of shares outstanding. An analysis of BVPS allows for a comparison of the market price against equity, which includes the costly cryogenic logistics infrastructure required for transporting gene therapies, thereby determining the business's actual margin of safety.

Competitors of REGENXBIO Inc. (RGNX)

Tempus AI, Inc. (TEM) - Net Assets per Single Share|Qiagen Corp (QGEN) - Equity per Share|Accounting Value per Share Ionis Pharmaceuticals|repligen.com (RGEN) - Equity per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share Twist Bioscience, Inc. (TWST)|TXG - Accounting Value of a Share|Book Value per Share NTLA|Stoke Corp (STOK) - Net Asset Value per Share|BioLife Solutions, Inc. - Book Value per Share|Book Value of One Share wavelifesciences.com|Maze Therapeutics - Book Value per Share|Net Asset Value per Share SION (Sionna Therapeutics, Inc.)|PRME - Net Assets per Single Share|TSHA - Equity per Share|uniQure N.V. (QURE) - Accounting Value per Share|MGTX - Equity per Share|Solid Biosciences (SLDB) - Book Value per Share|Ocugen Inc (OCGN) - Net Assets per Single Share|PACB: Book Value per Share|Net Assets per Share BNTC|Design Therapeutics - Net Assets per Single Share|Net Asset Value per Share rocketpharma.com RCKT|Accounting Value per Share 4D Molecular Therapeutics, Inc.|Accounting Value of a Share Lexeo Therapeutics Inc. LXEO|Book Value per Share KRRO (Korro Bio, Inc)|EDIT: Net Assets per Share|Net Assets per Single Share Silence Therapeutics|ProQR Therapeutics (PRQR) - Equity per Share|Book Value per Share CDXS|Accounting Value per Share Sangamo Therapeutics Inc. (SGMO)|NAUT (Nautilus Biotechnology) - Accounting Value per Share|Net Assets per Share MGX (Metagenomi Therapeutics)|Net Assets per Single Share Precision BioSciences, Inc.|Accounting Value of a Share Generation Bio Co GBIO|Book Value per Share BOLD|XCUR: Book Value of One Share|Net Assets per Single Share imunon.com|Equity per Share Phio Pharmaceuticals Corp.|Accounting Value per Share Mustang Bio Inc (MBIO)|Equity per Share TransCode|Book Value per Share Bionano Genomics, Inc. BNGO|Equity per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics - Book Value per Share|OMIC: Book Value per Share|Net Assets per Single Share Regulus Therapeutics Inc. RGLS|Syros Pharmaceuticals Inc. (SYRS) - Accounting Value of a Share|Book Value per Share TBIO (Codex DNA)|Net Asset Value per Share TRACON Pharmaceuticals, Inc|UBX: Book Value per Share